Both bitcoin and U.S. stock futures shot up on Monday after a U.S. pharmaceutical giant announced positive results from a large-scale clinical trial of a coronavirus vaccine.
- Risk appetite improved as Pfizer said its experimental vaccine has been 90% effective in preventing infections in the ongoing trial, Bloomberg reported.
- The news raises hopes that there may soon be an effective treatment for COVID-19, which is again running rampant through regions such as the U.S. and Europe.
- CoinDesk data shows that as the news broke, bitcoin jumped from $11,500 to $11,840 in the 15 minutes to 12:00 UTC.
- That came as the futures tied to the S&P 500 surged over 100 points to reach a record high of $3,648, and Dow Jones futures rose 1500 points.
- Gold, meanwhile, fell from $1,950 to $1,900 as investors sold safe-haven assets amid the rally on Wall Street.
- The coronavirus pandemic brought the global economy to a near standstill in the second quarter and its recent resurgence is threatening to derail the fragile economic recovery.
- The vaccine news, therefore, bodes well for growth-sensitive stocks and other risky assets.
- While the S&P 500 futures continue to trade near record highs, bitcoin has erased gains to trade near $10,500.
- The cryptocurrency's rally from October lows below $10,500 has stalled below $16,000 over the past couple of days, but, on Sunday, a weekly close above last year's high opened the door for a continued rally, possibly to a record high.
Also read: Bitcoin’s Weekly Close Above 2019 High Leaves Runway Clear to $20K
Disclosure
The leader in blockchain news, CoinDesk is a media outlet that strives for the highest journalistic standards and abides by a strict set of editorial policies. CoinDesk is an independent operating subsidiary of Digital Currency Group, which invests in cryptocurrencies and blockchain startups.